Intestinal Microbial and Metabolic Alterations Following Successful Fecal Microbiota Transplant for d-Lactic Acidosis
نویسندگان
چکیده
منابع مشابه
D-lactic acidosis: A rare cause of metabolic acidosis.
La acidosis por D-lactato es una causa muy poco frecuente de acidosis metabólica. Su incidencia es desconocida, pero probablemente sea más común de lo supuesto1. En los últimos años se ha descrito con más frecuencia, debido al incremento de la supervivencia de pacientes con síndrome de intestino corto (SIC), y al desarrollo de los programas de nutrición parenteral domiciliaria (NPD)2. Se presen...
متن کاملD(-)-lactic acid-producing probiotics, D(-)-lactic acidosis and infants.
There is mounting evidence that ingestion of selected probiotics can modify disease morbidity for specific conditions affecting humans, and there is growing interest in the amelioration or prevention of disease with probiotics. Modulation in gene expression of the cellular elements of the intestinal mucosa and interbacterial interactions are leading theories as to the mechanism whereby probioti...
متن کاملminimum requirements for reporting fecal microbiota transplant trial
fecal microbiota transplant (fmt) research trials are growing in diverse intestinal and extraintestinal conditions that are thought to be either caused or correlated with gut microbiota dysbiosis. although, the mechanism by which the microbiota results in disease initiation or progression is not fully understood, it is speculated that restoring the symbiosis by fmt could have therapeutic benefits.
متن کاملFecal Microbiota Transplant: Benefits and Risks
We commend the authors of “Weight Gain After Fecal Microbiota Transplantation” for describing this case of obesity after a fecal microbiota transplant (FMT). Fecal microbiota transplant is a highly effective therapy for recurrent Clostridium difficile infection (r-CDI), and the authors discuss possible unintended consequences in a patient after successful FMT, which could be due to alteration o...
متن کاملClostridium difficile Infection and Fecal Microbiota Transplant.
Clostridium difficile infection (CDI) is a major source of morbidity and mortality for hospitalized patients. Although most patients have a clinical response to existing antimicrobial therapies, recurrent infection develops in up to 30% of patients. Fecal microbiota transplant is a novel approach to this complex problem, with an efficacy rate of nearly 90% in the setting of multiple recurrent C...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Pediatric Gastroenterology & Nutrition
سال: 2018
ISSN: 0277-2116,1536-4801
DOI: 10.1097/mpg.0000000000002043